Stay updated on Safety of hESC-RPE in Stargardt's Clinical Trial
Sign up to get notified when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.

Latest updates to the Safety of hESC-RPE in Stargardt's Clinical Trial page
- Check4 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision indicator changed from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1; the study page remains a 403 error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden message, along with a minimal header, replacing the previous study content. As a result, the detailed study information, sponsor details, and related links are no longer visible to users.SummaryDifference17%

- Check67 days agoChange DetectedThe page shows Revision: v3.6.6, replacing the previous v3.6.5. This is a metadata update indicating a new version of the study record rather than a modification of study content.SummaryDifference0.1%

Stay in the know with updates to Safety of hESC-RPE in Stargardt's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.